Cincinnati Children's Hospital Medical Center

Cincinnati Children's Hospital Medical Center (CCHMC) is a premier nonprofit academic pediatric health system and research institution. Consistently ranked as the No. 1 or No. 2 pediatric hospital in the United States by U.S. News & World Report, it operates as a global leader in pediatric clinical care, research, and education. The organization serves as the primary pediatric teaching hospital for the University of Cincinnati College of Medicine. As a research powerhouse, CCHMC receives the third-highest amount of NIH funding among all pediatric centers in the U.S. Its Research Foundation oversees a vast portfolio of discovery-phase and clinical research, focusing on translating laboratory breakthroughs—such as organoid technology, gene therapy, and precision pharmacology—into novel bedside treatments. The center is renowned for historic contributions including the Sabin oral polio vaccine and more recent breakthroughs like the development of the HLH treatment Gamifant.